A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody

Todd A Jusko1, Anneclaire J De Roos, Stephen M Schwartz

  • 1Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709-2233, USA. juskota@niehs.nih.gov

Environmental Research
|April 10, 2010
PubMed

Insights

This study found no link between high polychlorinated biphenyls (PCBs) exposure in mothers and infants and infant antibody responses at six months. Developmental PCB exposure did not impact immune development in this cohort.

Area of Science:

  • Environmental Health
  • Immunotoxicology
  • Pediatric Health

Background:

  • Animal studies suggest prenatal polychlorinated biphenyls (PCBs) exposure alters offspring immune function.
  • Human data on developmental PCB exposure and immunologic development are limited.

Purpose of the Study:

  • To investigate the association between developmental PCB exposure and specific antibody responses in infants.
  • To assess the impact of maternal and early postnatal PCB exposure on infant immune development.

Main Methods:

  • Recruited 384 mother-infant pairs in eastern Slovakia.
  • Measured PCB congeners in maternal, cord, and infant sera using gas chromatography.
  • Assayed infant antibody concentrations (Haemophilus influenzae type b, tetanus, diphtheria) at 6 months via ELISA.

Main Results:

  • No significant association was observed between infant antibody concentrations and PCB levels during the pre- and early postnatal periods.
  • Results showed no specificity regarding developmental timing, antibody type, or PCB congener.

Conclusions:

  • Despite high PCB concentrations in the cohort, no association was detected between maternal or early postnatal PCB exposure and specific antibody responses at 6 months of age.
  • Developmental PCB exposure did not appear to affect specific antibody responses in this human cohort at the measured levels.
Abstract